Jeffrey Probstfield

4PUBLICATIONS
29CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Memory and attentionPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 13, 2026
FEV1 is a major prognostic factor in diverse heart failure populations: findings from the Global Heart Failure registry.

|Sep 08, 2022
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.

Kelley R H Branch, Gilles R Dagenais, Alvaro Avezum

|Apr 21, 2022
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.

Tali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile

|Nov 16, 2020
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.

Giulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun

Pageof 1

Frequent Collaborators

3 joint publications

Hertzel Gerstein

3 joint publications

Fernando Lanas

3 joint publications

Lawrence Alan Leiter

2 joint publications

Patricio Lopez-Jaramillo